VZ
27
-2
DD
49
-3
AVB
69
-5
AMT
62
-3
CFG
46
-2
NVDA
59
5
GS
70
4
RIG
26
-2
PNR
50
-12
HSIC
40
-4
AVGO
37
-3
ED
30
-3
EXC
47
-4
HD
46
-4
FITB
50
-2
ORLY
58
-3
JNJ
26
-4
CCL
50
-3
LEG
17
-5
XRAY
16
-3
VZ
27
-2
DD
49
-3
AVB
69
-5
AMT
62
-3
CFG
46
-2
NVDA
59
5
GS
70
4
RIG
26
-2
PNR
50
-12
HSIC
40
-4
AVGO
37
-3
ED
30
-3
EXC
47
-4
HD
46
-4
FITB
50
-2
ORLY
58
-3
JNJ
26
-4
CCL
50
-3
LEG
17
-5
XRAY
16
-3
Financhill
Back

Keros Therapeutics Stock Predictions

The Next Nvidia?

Go here now for this breaking story.
Sell
25

KROS
Keros Therapeutics

Last Price:
45.02
Seasonality Move:
4.22%

7 Day Trial

ALL ACCESS PASS

$ 7

This New Idea is Set to Shock the World

Click here to learn all the details.

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 14.7% based on the past 4 years of stock performance.
  • Keros Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 14.7% based on the past 4 years of stock performance.

Keros Therapeutics Stock Rating

Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
73.00
52-Week Low:
27.02

Prediction Charts

Market Cap:
1.65B
Price in USD:
45.65
Volume:
245.68K
Beta:
1.15

Technical Analysis

SMA50:
52.43
SMA100:
57.67
SMA200:
46.94
52-Wk Change:
10.05%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 45.65 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-5 49.39 49.45 50.17 48.86
Jun-6 49.45 48.69 49.45 47.88
Jun-7 48.01 48.69 49.58 47.94
Jun-10 47.96 48.88 49.60 46.78
Jun-11 48.41 47.87 48.93 47.38
Jun-12 48.98 48.98 49.70 48.45
Jun-13 48.80 49.50 50.21 48.18
Jun-14 48.89 49.36 49.51 47.29
Jun-17 49.30 44.58 49.37 43.57
Jun-18 43.57 44.65 45.39 43.40
Jun-20 44.18 45.31 46.68 43.30
Jun-21 45.64 46.44 46.69 45.22
Jun-24 46.40 46.49 46.95 45.78
Jun-25 47.20 45.65 47.20 45.12

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.